All posts by: Michael Zand

About Michael Zand

FDA Warns Stem Cell Supplier Over Unapproved Treatment – Regulatory Focus

Continue reading

2018-01-04 NEWS

FDA Warns Stem Cell Supplier Over Unapproved Treatment
Regulatory Focus
The US Food and Drug Administration (FDA) on Wednesday warned stem cell product supplier American CryoStem Corporation for marketing an unapproved product after the agency inspected the company’s Eatontown, New Jersey site in July. The warning letter

and more »

Continue reading

2018-01-04 NEWS

Investor’s Business Daily